Forbes Medi-Tech




Previous. All pages. Next. Page 1. Page 2

December 12, 2003  Forbes Achieves Major Milestone Towards European Approval of Reducol(tm)
December 09, 2003  Forbes Medi-Tech Expands Plant Capacity to 1,500 Metric Tonnes ~Demand for Sterols Supports Phyto-Source Expansion~
December 03, 2003  Forbes Medi-Tech Files U.S. Registration Statement Pursuant to Previous Financing
November 25, 2003  Forbes Medi-Tech announces Financial Results for the Third Quarter ended September 30, 2003
November 17, 2003  Forbes Medi-Tech Announces Timing of Third Quarter Financial Results
October 22, 2003  Forbes Medi-Tech Co-Sponsors CIHR Research Chair with Dr. Kishor Wasan
September 16, 2003  Forbes Medi-Tech Appoints New Member to Board of Directors
September 05, 2003  Forbes Medi-Tech Raises US$4.65 Million in Equity Financing
August 20, 2003  Forbes Medi-Tech Receives Approval for Nasdaq National Market Listing
August 19, 2003  Forbes Medi-Tech announces Financial Results for the Second Quarter ended June 30, 2003 - Second Quarter Revenues up 30%, Company Improves Operating Results
August 13, 2003  Forbes Medi-Tech Announces Closing of Phyto-Source Financing
August 12, 2003  Forbes Medi-Tech Announces Timing of Second Quarter Financial Results
July 18, 2003  Forbes Medi-Tech Signs International Reducol (tm) Sales and Licensing Agreement
July 15, 2003  Forbes Medi-Tech Maintains Nasdaq SmallCap Listing
July 02, 2003  Forbes Medi-Tech To Receive US$3 Million Partial Loan Repayment From Phyto-Source Manufacturing Joint Venture
June 27, 2003  Forbes Medi-Tech Announces US$2 Million Increase in Revenue Guidance Based on Growth in Sterol Sales
May 30, 2003  Forbes Medi-Tech AGM Update
May 05, 2003  Forbes Medi-Tech announces Financial Results for the Year ended December 31, 2002 and First Quarter ended March 31, 2003
May 01, 2003  Forbes Medi-Tech Announces Timing of Year End, First Quarter Financial Results and AGM
April 29, 2003  Forbes Medi-Tech Responds to Pan Pharmaceutical News
April 29, 2003  Forbes Medi-Tech Sells AD & ADD Technology for US$1.9 Million
April 16, 2003  Forbes Medi-Tech Announces NASDAQ Extension and Advisory Board Restructuring
March 04, 2003  Forbes Medi-Tech Announces Pharmavite Contract Extension
February 27, 2003  US FDA Issues Health Claim Letter to Forbes
January 27, 2003  Forbes Medi-Tech Completes Phase I Safety Study on FM-VP4

Previous. All pages. Next. Page 1. Page 2